Research shows innovative approach serves health care consumers over long term.
Dr. Diana Buist explains the new Breast Cancer Surveillance Consortium study in JAMA Oncology, which she co-wrote.
Based on a new BCSC study, Dr. Diana Buist tells of technology that adds cost to breast cancer screening—without improving outcomes. Dr. Marc Mora comments.
CAD raises screening costs without benefit to patients and may miss cancers, large national BCSC study shows.
Before journalist Laurie Becklund died, she called for Big Data research on cancer. That’s exactly what the Breast Cancer Surveillance Consortium does.
A study to help kids with cancer get time with pets begins field work, with encouragement from a GHRI interest group.
A Breast Cancer Surveillance Consortium study involving Group Health shows that density shouldn’t be the only factor when considering additional screening.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.